Cooper Companies (COO) Competitors

Cooper Companies logo
$60.98 +0.26 (+0.42%)
As of 01:48 PM Eastern
This is a fair market value price provided by Massive. Learn more.

COO vs. ALC, WST, SOLV, ALGN, and BLCO

Should you buy Cooper Companies stock or one of its competitors? Cooper Companies's main competitors and comparable companies include Alcon (ALC), West Pharmaceutical Services (WST), Solventum (SOLV), Align Technology (ALGN), and Bausch + Lomb (BLCO). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does Cooper Companies compare to Alcon?

Cooper Companies (NASDAQ:COO) and Alcon (NYSE:ALC) are both large-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and media sentiment.

24.4% of Cooper Companies shares are held by institutional investors. Comparatively, 53.9% of Alcon shares are held by institutional investors. 2.1% of Cooper Companies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Cooper Companies has a net margin of 13.46% compared to Alcon's net margin of 6.06%. Cooper Companies' return on equity of 10.90% beat Alcon's return on equity.

Company Net Margins Return on Equity Return on Assets
Cooper Companies13.46% 10.90% 7.24%
Alcon 6.06%7.54%5.25%

In the previous week, Cooper Companies had 11 more articles in the media than Alcon. MarketBeat recorded 27 mentions for Cooper Companies and 16 mentions for Alcon. Cooper Companies' average media sentiment score of 0.51 beat Alcon's score of 0.30 indicating that Cooper Companies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cooper Companies
10 Very Positive mention(s)
5 Positive mention(s)
5 Neutral mention(s)
7 Negative mention(s)
0 Very Negative mention(s)
Positive
Alcon
4 Very Positive mention(s)
2 Positive mention(s)
9 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Cooper Companies has a beta of 0.83, suggesting that its stock price is 17% less volatile than the broader market. Comparatively, Alcon has a beta of 0.87, suggesting that its stock price is 13% less volatile than the broader market.

Cooper Companies currently has a consensus target price of $68.60, suggesting a potential upside of 12.98%. Alcon has a consensus target price of $82.16, suggesting a potential upside of 10.72%. Given Cooper Companies' higher possible upside, equities analysts plainly believe Cooper Companies is more favorable than Alcon.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cooper Companies
3 Sell rating(s)
12 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.05
Alcon
1 Sell rating(s)
6 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
2.63

Alcon has higher revenue and earnings than Cooper Companies. Cooper Companies is trading at a lower price-to-earnings ratio than Alcon, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cooper Companies$4.09B2.82$374.90M$2.9320.72
Alcon$10.40B3.53$980M$1.3754.16

Summary

Alcon beats Cooper Companies on 9 of the 17 factors compared between the two stocks.

How does Cooper Companies compare to West Pharmaceutical Services?

Cooper Companies (NASDAQ:COO) and West Pharmaceutical Services (NYSE:WST) are both large-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, earnings, media sentiment, analyst recommendations, institutional ownership, profitability, valuation and risk.

West Pharmaceutical Services has lower revenue, but higher earnings than Cooper Companies. Cooper Companies is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cooper Companies$4.09B2.82$374.90M$2.9320.72
West Pharmaceutical Services$3.07B9.38$493.70M$8.9146.46

24.4% of Cooper Companies shares are held by institutional investors. Comparatively, 93.9% of West Pharmaceutical Services shares are held by institutional investors. 2.1% of Cooper Companies shares are held by company insiders. Comparatively, 0.6% of West Pharmaceutical Services shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Cooper Companies has a beta of 0.83, suggesting that its stock price is 17% less volatile than the broader market. Comparatively, West Pharmaceutical Services has a beta of 1.13, suggesting that its stock price is 13% more volatile than the broader market.

In the previous week, Cooper Companies had 22 more articles in the media than West Pharmaceutical Services. MarketBeat recorded 27 mentions for Cooper Companies and 5 mentions for West Pharmaceutical Services. West Pharmaceutical Services' average media sentiment score of 1.04 beat Cooper Companies' score of 0.51 indicating that West Pharmaceutical Services is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cooper Companies
10 Very Positive mention(s)
5 Positive mention(s)
5 Neutral mention(s)
7 Negative mention(s)
0 Very Negative mention(s)
Positive
West Pharmaceutical Services
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

West Pharmaceutical Services has a net margin of 18.81% compared to Cooper Companies' net margin of 13.46%. West Pharmaceutical Services' return on equity of 21.78% beat Cooper Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
Cooper Companies13.46% 10.90% 7.24%
West Pharmaceutical Services 18.81%21.78%15.99%

Cooper Companies presently has a consensus price target of $68.60, suggesting a potential upside of 12.98%. West Pharmaceutical Services has a consensus price target of $424.67, suggesting a potential upside of 2.58%. Given Cooper Companies' higher probable upside, equities research analysts clearly believe Cooper Companies is more favorable than West Pharmaceutical Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cooper Companies
3 Sell rating(s)
12 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.05
West Pharmaceutical Services
0 Sell rating(s)
1 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.93

Summary

West Pharmaceutical Services beats Cooper Companies on 12 of the 16 factors compared between the two stocks.

How does Cooper Companies compare to Solventum?

Solventum (NYSE:SOLV) and Cooper Companies (NASDAQ:COO) are both large-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, media sentiment, profitability, dividends, valuation and institutional ownership.

Solventum has higher revenue and earnings than Cooper Companies. Cooper Companies is trading at a lower price-to-earnings ratio than Solventum, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Solventum$8.33B1.76$1.56B$0.8996.89
Cooper Companies$4.09B2.82$374.90M$2.9320.72

In the previous week, Cooper Companies had 22 more articles in the media than Solventum. MarketBeat recorded 27 mentions for Cooper Companies and 5 mentions for Solventum. Solventum's average media sentiment score of 0.80 beat Cooper Companies' score of 0.51 indicating that Solventum is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Solventum
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cooper Companies
10 Very Positive mention(s)
5 Positive mention(s)
5 Neutral mention(s)
7 Negative mention(s)
0 Very Negative mention(s)
Positive

Cooper Companies has a net margin of 13.46% compared to Solventum's net margin of 1.91%. Solventum's return on equity of 25.03% beat Cooper Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
Solventum1.91% 25.03% 8.65%
Cooper Companies 13.46%10.90%7.24%

24.4% of Cooper Companies shares are owned by institutional investors. 0.2% of Solventum shares are owned by insiders. Comparatively, 2.1% of Cooper Companies shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Solventum has a beta of 0.69, meaning that its stock price is 31% less volatile than the broader market. Comparatively, Cooper Companies has a beta of 0.83, meaning that its stock price is 17% less volatile than the broader market.

Solventum presently has a consensus target price of $90.27, indicating a potential upside of 4.68%. Cooper Companies has a consensus target price of $68.60, indicating a potential upside of 12.98%. Given Cooper Companies' higher probable upside, analysts clearly believe Cooper Companies is more favorable than Solventum.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Solventum
1 Sell rating(s)
3 Hold rating(s)
9 Buy rating(s)
1 Strong Buy rating(s)
2.71
Cooper Companies
3 Sell rating(s)
12 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.05

Summary

Solventum beats Cooper Companies on 9 of the 17 factors compared between the two stocks.

How does Cooper Companies compare to Align Technology?

Align Technology (NASDAQ:ALGN) and Cooper Companies (NASDAQ:COO) are both large-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, dividends, profitability, valuation, earnings, risk and institutional ownership.

In the previous week, Cooper Companies had 21 more articles in the media than Align Technology. MarketBeat recorded 27 mentions for Cooper Companies and 6 mentions for Align Technology. Align Technology's average media sentiment score of 1.41 beat Cooper Companies' score of 0.51 indicating that Align Technology is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Align Technology
5 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cooper Companies
10 Very Positive mention(s)
5 Positive mention(s)
5 Neutral mention(s)
7 Negative mention(s)
0 Very Negative mention(s)
Positive

Cooper Companies has a net margin of 13.46% compared to Align Technology's net margin of 11.83%. Align Technology's return on equity of 15.96% beat Cooper Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
Align Technology11.83% 15.96% 10.48%
Cooper Companies 13.46%10.90%7.24%

Align Technology has a beta of 1.74, indicating that its share price is 74% more volatile than the broader market. Comparatively, Cooper Companies has a beta of 0.83, indicating that its share price is 17% less volatile than the broader market.

Align Technology presently has a consensus price target of $193.08, indicating a potential upside of 18.12%. Cooper Companies has a consensus price target of $68.60, indicating a potential upside of 12.98%. Given Align Technology's stronger consensus rating and higher possible upside, equities analysts clearly believe Align Technology is more favorable than Cooper Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Align Technology
0 Sell rating(s)
8 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.59
Cooper Companies
3 Sell rating(s)
12 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.05

88.4% of Align Technology shares are held by institutional investors. Comparatively, 24.4% of Cooper Companies shares are held by institutional investors. 0.8% of Align Technology shares are held by company insiders. Comparatively, 2.1% of Cooper Companies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Align Technology has higher earnings, but lower revenue than Cooper Companies. Cooper Companies is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Align Technology$4.03B2.86$410.35M$6.8723.79
Cooper Companies$4.09B2.82$374.90M$2.9320.72

Summary

Align Technology beats Cooper Companies on 13 of the 17 factors compared between the two stocks.

How does Cooper Companies compare to Bausch + Lomb?

Bausch + Lomb (NYSE:BLCO) and Cooper Companies (NASDAQ:COO) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, risk, earnings, valuation, institutional ownership and media sentiment.

Bausch + Lomb currently has a consensus target price of $21.08, indicating a potential upside of 1.20%. Cooper Companies has a consensus target price of $68.60, indicating a potential upside of 12.98%. Given Cooper Companies' higher possible upside, analysts clearly believe Cooper Companies is more favorable than Bausch + Lomb.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bausch + Lomb
1 Sell rating(s)
8 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.40
Cooper Companies
3 Sell rating(s)
12 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.05

11.1% of Bausch + Lomb shares are held by institutional investors. Comparatively, 24.4% of Cooper Companies shares are held by institutional investors. 1.5% of Bausch + Lomb shares are held by insiders. Comparatively, 2.1% of Cooper Companies shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Cooper Companies had 23 more articles in the media than Bausch + Lomb. MarketBeat recorded 27 mentions for Cooper Companies and 4 mentions for Bausch + Lomb. Bausch + Lomb's average media sentiment score of 0.67 beat Cooper Companies' score of 0.51 indicating that Bausch + Lomb is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bausch + Lomb
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cooper Companies
10 Very Positive mention(s)
5 Positive mention(s)
5 Neutral mention(s)
7 Negative mention(s)
0 Very Negative mention(s)
Positive

Cooper Companies has a net margin of 13.46% compared to Bausch + Lomb's net margin of -2.05%. Cooper Companies' return on equity of 10.90% beat Bausch + Lomb's return on equity.

Company Net Margins Return on Equity Return on Assets
Bausch + Lomb-2.05% 5.01% 2.34%
Cooper Companies 13.46%10.90%7.24%

Bausch + Lomb has a beta of 0.52, suggesting that its stock price is 48% less volatile than the broader market. Comparatively, Cooper Companies has a beta of 0.83, suggesting that its stock price is 17% less volatile than the broader market.

Cooper Companies has lower revenue, but higher earnings than Bausch + Lomb. Bausch + Lomb is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bausch + Lomb$5.10B1.46-$360M-$0.31N/A
Cooper Companies$4.09B2.82$374.90M$2.9320.72

Summary

Cooper Companies beats Bausch + Lomb on 12 of the 17 factors compared between the two stocks.

Get Cooper Companies News Delivered to You Automatically

Sign up to receive the latest news and ratings for COO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding COO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

COO vs. The Competition

MetricCooper CompaniesHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$11.59B$5.96B$7.66B$11.73B
Dividend YieldN/A1.68%2.47%4.46%
P/E Ratio20.8138.9634.0030.04
Price / Sales2.835.458.445.70
Price / Cash10.2223.6221.0121.90
Price / Book1.474.244.483.75
Net Income$374.90M$143.92M$3.51B$394.12M
7 Day Performance-3.11%-5.22%-5.93%-5.63%
1 Month Performance5.24%-3.34%-4.31%-6.93%
1 Year Performance-15.55%0.43%-1.15%-7.12%

Cooper Companies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
COO
Cooper Companies
3.6239 of 5 stars
$60.98
+0.4%
$68.60
+12.5%
-14.9%$11.59B$4.09B20.8115,000
ALC
Alcon
2.6145 of 5 stars
$73.22
+1.9%
$82.16
+12.2%
-3.1%$36.21B$10.40B53.4325,942
WST
West Pharmaceutical Services
3.8195 of 5 stars
$409.89
-0.3%
$424.67
+3.6%
+57.8%$28.53B$3.07B45.9710,800
SOLV
Solventum
1.6082 of 5 stars
$88.92
+0.1%
$90.27
+1.5%
+13.4%$15.09B$8.33B99.9120,000
ALGN
Align Technology
3.86 of 5 stars
$169.01
+1.2%
$193.08
+14.2%
+23.3%$11.93B$4.03B24.6320,290

Related Companies and Tools


This page (NASDAQ:COO) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners